TICKER INTELLIGENCE
NYSE/NASDAQ: CAG
2
Active Bills
1
Gov't Contracts
50
Congressional Trades
$CAG is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 3 active Congressional signals mentioning $CAG, including 2 bills and 1 federal contract. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
⚠ ⚠️ PRESIDENTIAL ACTION: Presidential Memorandum signed 7/30/2026: "Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended". This DPA action will boost investment and production in domestic critical mineral recycling and processing, likely increasing stock valuations for pure-play recovery companies and defense contractors reliant on secure rare-earth magnet supplies, while potentially raising costs for import-dependent manufacturers.
⚠ ⚠️ PRESIDENTIAL ACTION: Presidential Action signed 7/20/2026: "Imposing Additional Duties to Offset Canadian Discrimination Against the Commerce of the United Stat". The 50% tariff on Canadian goods will increase costs for U.S. importers and consumers of affected products, potentially boosting domestic dairy and manufacturing sectors while straining U.S.-Canada trade relations and raising prices for consumers.
⚠ Rep. Cisneros bought $1K-$15K in CRWD on May 15, 2026 — 5 days before HR8880 (a bill boosting cybersecurity for small businesses) was introduced.
⚠ System: No overlapping signals found
⚠ System: No valid trades to analyze
⚠ System: No overlapping signals found
⚠ System: No valid trades to analyze
⚠ System: No overlapping signals found
⚠ Gilbert Cisneros bought $100,001 - $250,000 in TSM on 2026-02-09, one day before S2722, the "Taiwan Energy Security and Anti-Embargo Act of 2026," advanced to the Senate Legislative Calendar, a bullish signal for the company.
⚠ System: No valid trades to analyze
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ Gilbert Cisneros bought $1,001 - $15,000 in LMT on 2025-08-05, 56 days before the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 (HR3838) was enacted, which significantly impacts defense contractors.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ Gilbert Cisneros bought $15,001 - $50,000 in JNJ on 2025-05-30, 6 days before the 'Treat and Reduce Obesity Act of 2025' (S1973) was introduced, which aims to expand Medicare coverage for obesity treatments.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ Rep. Johnson bought $1K-$15K in MRK on Jan 17, 2025 — 35 days before HR1492 was introduced, a bill extending Medicare price-negotiation protections for small-molecule drugs like those from Merck.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No valid trades to analyze
⚠ System: No valid trades to analyze
⚠ System: No valid trades to analyze
⚠ System: No suspicious timing patterns detected
⚠ System: No overlapping signals found
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
HR8431 is an early-stage bill that would expand the FDA's accredited third-party certification program for food safety audits. With zero funding authorization and no direct causal chain to any publicly traded company at this stage, it has no near-term market impact.
The FSMA Fee Technical Corrections Act is a procedural bill that adjusts FDA reinspection and recall fees to a $15,000 inflation-adjusted base for large food manufacturers starting FY2026. The bill is early-stage (referred to committee) with no market-moving impact. Real market data shows no correlation with this bill—the sector's 30-day declines (GIS -5.83%, CAG -9.35%, CPB -7.45%, HSY -11.38%) reflect broader consumer staples weakness, not legislative action.
→ Event-driven cost increase for any facility that triggers FDA reinspection or a recall order. Fee is immaterial relative to Conagra's revenue ($12B+ annually).
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →